FC023235 2021-01-01 2021-12-31 FC023235 2022-01-01 2022-12-31 FC0232352021-01-012021-12-31example1:AdjustedOperatingProfitLossMemberexample1:ImpairmentLossesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedOperatingProfitLossMemberexample1:LitigationExpensesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedOperatingProfitLossMemberexample1:RestructuringExpensesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedOperatingProfitLossMemberexample1:GainsOnDisposalOfAssociatesAndJointVenturesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedOperatingProfitLossMemberifrs-full:ValueOfManagementdefinedPerformanceMeasureMember FC0232352021-01-012021-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:ImpairmentLossesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:LitigationExpensesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:RestructuringExpensesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:GainsOnDisposalOfAssociatesAndJointVenturesAdjustmentMember FC0232352021-01-012021-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberifrs-full:ValueOfManagementdefinedPerformanceMeasureMember FC0232352022-01-012022-12-31example1:AdjustedOperatingProfitLossMemberexample1:ImpairmentLossesAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedOperatingProfitLossMemberexample1:LitigationExpensesAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedOperatingProfitLossMemberexample1:RestructuringExpensesAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedOperatingProfitLossMemberexample1:GainsOnDisposalOfPropertyPlantAndEquipmentAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedOperatingProfitLossMemberifrs-full:ValueOfManagementdefinedPerformanceMeasureMember FC0232352022-01-012022-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:ImpairmentLossesAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:LitigationExpensesAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:RestructuringExpensesAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberexample1:GainsOnDisposalOfPropertyPlantAndEquipmentAdjustmentMember FC0232352022-01-012022-12-31example1:AdjustedProfitLossFromContinuingOperationsMemberifrs-full:ValueOfManagementdefinedPerformanceMeasureMember FC0232352021-01-012021-12-31ifrs-full:DepreciationMember FC0232352021-01-012021-12-31ifrs-full:AmortisationMember FC0232352021-01-012021-12-31ifrs-full:EmployeeBenefitsMember FC0232352021-01-012021-12-31ifrs-full:ImpairmentLossReversalOfImpairmentLossMember FC0232352021-01-012021-12-31ifrs-full:WritedownReversalOfWritedownOfInventoriesMember FC0232352022-01-012022-12-31ifrs-full:DepreciationMember FC0232352022-01-012022-12-31ifrs-full:AmortisationMember FC0232352022-01-012022-12-31ifrs-full:EmployeeBenefitsMember FC0232352022-01-012022-12-31ifrs-full:ImpairmentLossReversalOfImpairmentLossMember FC0232352022-01-012022-12-31ifrs-full:WritedownReversalOfWritedownOfInventoriesMember iso4217:EUR iso4217:EUR xbrli:shares
IFRS Foundation

Part I—Examples of presentation and disclosure

XYZ Group—Statement of profit or loss for the year ended 31 December 20X2

(in thousands of Currency Units)
20X2 20X1
Revenue 367,000 353,100
Cost of sales (241,600) (224,100)
Gross profit 125,400 129,000
Other operating income 12,200 4,100
Selling expenses (28,900) (27,400)
Research and development expenses (25,100) (25,900)
General and administrative expenses (20,900) (22,400)
Goodwill impairment loss (4,500) –
Other operating expenses (1,200) (5,600)
Operating profit 57,000 51,800
Share of profit and gains on disposal of associates and joint ventures 5,300 7,300
Profit before financing and income taxes 62,300 59,100
Interest expenses on borrowings and lease liabilities (13,000) (13,200)
Interest expenses on pension liabilities and provisions (6,500) (6,000)
Profit before income taxes 42,800 39,900
Income tax expense (10,700) (9,975)
Profit from continuing operations 32,100 29,925
Loss from discontinued operations – (5,500)
PROFIT 32,100 24,425
Profit attributable to:
Owners of the parent 25,680 19,540
Non-controlling interests 6,420 4,885
32,100 24,425
Earnings per share from continuing operations:
Basic and diluted 0.67 0.66
Earnings per share:
Basic and diluted 0.67 0.54

Note 1—Specified expenses by nature

(in thousands of CU)
20X2 20X1
Depreciation
Cost of sales 23,710 21,990
Research and development expenses 2,515 2,590
General and administrative expenses 4,975 4,750
Total depreciation 31,200 29,330
Amortisation
Research and development expenses 13,840 12,690
Total amortisation 13,840 12,690
Employee benefits
Cost of sales 61,640 57,175
Selling expenses 7,515 7,110
Research and development expenses 6,545 6,750
General and administrative expenses 8,920 5,825
Total employee benefits 84,620 76,860
Impairment losses
Research and development expenses 1,600 1,500
Goodwill impairment loss 4,500 –
Total impairment losses 6,100 1,500
Write-down of inventories
Cost of sales 2,775 2,625
Total write-down of inventories 2,775 2,625

Note 2—Management-defined performance measures

Management-defined performance measures 20X2 (in thousands of CU)
Adjusting items
IFRS Impairment losses Restructuring expenses Gains on disposal Management-defined
of property, plant performance
and equipment measure
Other operating income – – (1800)
Research and development expenses 1600 – –
General and administrative expenses – 3800 –
Goodwill impairment loss 4500 – –
Operating profit / Adjusted operating profit 57,000 6,100 3,800 (1800) 65,100
Income tax expense – (589) 297
Profit from continuing operations / Adjusted profit from continuing operations 32,100 6,100 3,211 (1503) 39,908
Profit attributable to non-controlling interests 305 161 –

Management-defined performance measures 20X1 (in thousands of CU)
Adjusting items
IFRS Impairment losses Litigation expenses Gains on disposal of associates and Management-defined
joint ventures performance
measure
Research and development expenses 1,500 – –
General and administrative expenses – 3,500 –
Operating profit / Adjusted operating profit 51,800 1,500 3,500 – 56,800
Share of profit and gains on disposal of associates and joint ventures – – (2200)
Income tax expense – – 319
Profit from continuing operations / Adjusted profit from continuing operations 29,925 1,500 3,500 (1,881) 33,044
Profit attributable to non-controlling interests 75 – –

Copyright © 2025 IFRS Foundation

All rights reserved. Reproduction and use rights are strictly limited. Please contact the Foundation for further details at licences@ifrs.org .

The Foundation has trade marks registered around the world (Marks) including ‘IAS®’, ‘IASB®’, the IASB® logo, ‘IFRIC®’, ‘IFRS®’, the IFRS® logo, ‘IFRS for SMEs®’, the IFRS for SMEs® logo, ‘International Accounting Standards®’, ‘International Financial Reporting Standards®’, the ‘Hexagon Device’, ‘NIIF®’ and ‘SIC®’. Further details of the Foundation’s Marks are available from the Foundation on request.